(19)
(11) EP 3 204 422 A1

(12)

(43) Date of publication:
16.08.2017 Bulletin 2017/33

(21) Application number: 15848683.7

(22) Date of filing: 07.10.2015
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
A61K 39/395(2006.01)
(86) International application number:
PCT/US2015/054490
(87) International publication number:
WO 2016/057667 (14.04.2016 Gazette 2016/15)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA

(30) Priority: 10.10.2014 US 201462062431 P

(71) Applicant: Medimmune, LLC
Gaithersburg, Maryland 20878 (US)

(72) Inventors:
  • HAMMOND, Scott A.
    Gaithersburg, MD 20878 (US)
  • OBERST, Michael
    Gaithersburg, MD 20878 (US)
  • DU, Qun
    Gaithersburg, MD 20878 (US)
  • DAMSCHRODER, Melissa
    Gaithersburg, MD 20878 (US)

(74) Representative: Winter, Christopher Spencer et al
MedImmune Limited Milstein Building Granta Park
Cambridge CB21 6GH
Cambridge CB21 6GH (GB)

   


(54) HUMANIZED ANTI-OX40 ANTIBODIES AND USES THEREOF